RLAY Q2 2024 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$101M

Net Income

-$92M

EPS (Diluted)

$-0.69

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$66M

Free Cash Flow

-$66M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$773M

Total Liabilities

$91M

Stockholders' Equity

$682M

Cash & Equivalents

$134M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$119,000	-100.0%
Gross Profit	$0	-$88M	+100.0%
Operating Income	-$101M	-$106M	+5.0%
Net Income	-$92M	-$99M	+6.4%